UBS Group AG - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 24 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$3,721
-23.3%
10,630
-51.8%
0.00%
Q4 2022$4,852
-59.6%
22,055
-37.9%
0.00%
Q3 2022$12,000
-14.3%
35,517
+419.3%
0.00%
Q1 2022$14,000
+40.0%
6,840
+88.7%
0.00%
Q4 2021$10,000
-47.4%
3,624
-17.4%
0.00%
Q3 2021$19,000
+72.7%
4,390
-1.3%
0.00%
Q1 2021$11,000
-42.1%
4,447
-60.0%
0.00%
Q4 2020$19,000
+533.3%
11,119
+741.7%
0.00%
Q3 2020$3,0000.0%1,321
-21.9%
0.00%
Q2 2019$3,000
-76.9%
1,692
-55.4%
0.00%
Q1 2019$13,000
-7.1%
3,791
+39.2%
0.00%
Q4 2018$14,000
+600.0%
2,723
+388.0%
0.00%
Q3 2018$2,0005580.00%
Other shareholders

There were no reported owners of ADIAL PHARMACEUTICALS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of ADIAL PHARMACEUTICALS INC shareholders